{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:49:24Z","timestamp":1777384164572,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To revisit the autosomal dominant Sorsby fundus dystrophy (SFD) as a syndromic condition including late-onset pulmonary disease. We report clinical and imaging data of ten affected individuals from 2 unrelated families with SFD and carrying heterozygous\n                    <jats:italic>TIMP3<\/jats:italic>\n                    mutations (c.572A\u2009&gt;\u2009G, p.Y191C, exon 5, in family 1 and c.113C\u2009&gt;\u2009G, p.S38C, exon 1, in family 2). In family 1, all SFD patients older than 50 (two generations) had also a severe emphysema, despite no history of smoking or asthma. In the preceding generation, the mother died of pulmonary emphysema and she was blind after the age of 50. Her two great-grandsons (&lt;20 years), had abnormal Bruch Membrane thickness, a sign of eye disease. In family 2, eye and lung diseases were also associated in two generations, both occurred later and lung disease was moderate (bronchiectasis). This is the first report of a syndromic SFD in line with the mouse model uncovering the role of TIMP3 in human lung morphogenesis and functions. The\n                    <jats:italic>TIMP3<\/jats:italic>\n                    gene should be screened in familial pulmonary diseases with bronchiectasis, associated with a medical history of visual loss. In addition, SFD patients should be advised to avoid tobacco consumption, to practice sports and to undergo regular pulmonary examinations.\n                  <\/jats:p>","DOI":"10.1038\/srep32544","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T05:34:14Z","timestamp":1473226454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A new autosomal dominant eye and lung syndrome linked to mutations in TIMP3 gene"],"prefix":"10.1038","volume":"6","author":[{"given":"Isabelle","family":"Meunier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Bocquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Labesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Zeitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Defoort-Dhellemmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Lacroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Mauget-Faysse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Drumare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Sophie","family":"Gamez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Marquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lola","family":"Sagot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire-Marie","family":"Dhaenens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Remy-Jardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salomon Yves","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Alain","family":"Sahel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Puech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Audo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Mrejen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian P.","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,7]]},"reference":[{"key":"BFsrep32544_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/bjo.33.2.67","volume":"33","author":"A Sorsby","year":"1949","unstructured":"Sorsby, A., Mason, M. E. J. & Gardener, N. A Fundus dystrophy with unusual features (Late onset and dominant inheritance of a central retinal lesion showing oedema, haemorrhage and exudates developing into generalised choroidal atrophy with massive pigment proliferation). Br. J. Ophthalmol. 33, 67\u201397 (1949).","journal-title":"Br. J. Ophthalmol."},{"key":"BFsrep32544_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng1294-352","volume":"8","author":"BH Weber","year":"1994","unstructured":"Weber, B. H., Vogt, G., Pruett, R. C., St\u00f6hr, H. & Felbor, U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby\u2019s fundus dystrophy. Nat. Genet. 8, 352\u2013356 (1994).","journal-title":"Nat. Genet."},{"key":"BFsrep32544_CR3","first-page":"2732","volume":"43","author":"BHF Weber","year":"2002","unstructured":"Weber, B. H. F. et al. A mouse model for Sorsby fundus dystrophy. Invest. Ophthalmol. Vis. Sci. 43, 2732\u20132740 (2002).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFsrep32544_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nm846","volume":"9","author":"JH Qi","year":"2003","unstructured":"Qi, J. H. et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 9, 407\u2013415 (2003).","journal-title":"Nat. Med."},{"key":"BFsrep32544_CR5","doi-asserted-by":"publisher","first-page":"20557","DOI":"10.3390\/molecules191220557","volume":"19","author":"N Pescosolido","year":"2014","unstructured":"Pescosolido, N. et al. Role of Protease-Inhibitors in Ocular Diseases. Molecules 19, 20557\u201320569 (2014).","journal-title":"Molecules"},{"key":"BFsrep32544_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s10517-007-0018-x","volume":"143","author":"GT Sukhikh","year":"2007","unstructured":"Sukhikh, G. T. & Soboleva, G. M. Sorsby fundus dystrophy-related mutation in tissue inhibitor of metalloproteinases-3 impairs regulation of its expression in mouse fibroblasts. Bull. Exp. Biol. Med. 143, 64\u201367 (2007).","journal-title":"Bull. Exp. Biol. Med."},{"key":"BFsrep32544_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-4615-0067-4_13","volume":"533","author":"JH Qi","year":"2003","unstructured":"Qi, J. H., Ebrahem, Q. & Anand-Apte, B. Tissue inhibitor of metalloproteinases-3 and Sorsby fundus dystrophy. Adv. Exp. Med. Biol. 533, 97\u2013105 (2003).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFsrep32544_CR8","first-page":"1218","volume":"15","author":"Z Saihan","year":"2009","unstructured":"Saihan, Z. et al. Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy. Mol. Vis. 15, 1218\u20131230 (2009).","journal-title":"Mol. Vis."},{"key":"BFsrep32544_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.4049\/jimmunol.176.2.721","volume":"176","author":"DS Smookler","year":"2006","unstructured":"Smookler, D. S. et al. Cutting Edge: Tissue Inhibitor of Metalloproteinase 3 Regulates TNF-Dependent Systemic Inflammation. J. Immunol. 176, 721\u2013725 (2006).","journal-title":"J. Immunol."},{"key":"BFsrep32544_CR10","first-page":"817","volume":"38","author":"B Anand-Apte","year":"1997","unstructured":"Anand-Apte, B. et al. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest. Ophthalmol. Vis. Sci. 38, 817\u2013823 (1997).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFsrep32544_CR11","doi-asserted-by":"publisher","first-page":"19927","DOI":"10.1074\/jbc.M109.013763","volume":"284","author":"JH Qi","year":"2009","unstructured":"Qi, J. H. et al. S156C Mutation in Tissue Inhibitor of Metalloproteinases-3 Induces Increased Angiogenesis. J. Biol. Chem. 284, 19927\u201319936 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32544_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/jcp.10361","volume":"197","author":"G Soboleva","year":"2003","unstructured":"Soboleva, G., Geis, B., Schrewe, H. & Weber, B. H. F. Sorsby fundus dystrophy mutation Timp3 (S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis. J. Cell. Physiol. 197, 149\u2013156 (2003).","journal-title":"J. Cell. Physiol."},{"key":"BFsrep32544_CR13","doi-asserted-by":"publisher","first-page":"30469","DOI":"10.1074\/jbc.M403026200","volume":"279","author":"PA Klenotic","year":"2004","unstructured":"Klenotic, P. A., Munier, F. L., Marmorstein, L. Y. & Anand-Apte, B. Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) Is a Binding Partner of Epithelial Growth Factor-containing Fibulin-like Extracellular Matrix Protein 1 (EFEMP1) IMPLICATIONS FOR MACULAR DEGENERATIONS. J. Biol. Chem. 279, 30469\u201330473 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32544_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1136\/bjo.35.12.751","volume":"35","author":"N Ashton","year":"1951","unstructured":"Ashton, N. & Sorsby, A. Fundus Dystrophy with Unusual Features. Br. J. Ophthalmol. 35, 751\u2013764 (1951).","journal-title":"Br. J. Ophthalmol."},{"key":"BFsrep32544_CR15","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0161-6420(89)32664-9","volume":"96","author":"MR Capon","year":"1989","unstructured":"Capon, M. R. et al. Sorsby\u2019s fundus dystrophy. A light and electron microscopic study. Ophthalmology 96, 1769\u20131777 (1989).","journal-title":"Ophthalmology"},{"key":"BFsrep32544_CR16","doi-asserted-by":"crossref","unstructured":"Cigarette smoking and health. American Thoracic Society. Am. J. Respir. Crit. Care Med. 153, 861\u2013865 (1996).","DOI":"10.1164\/ajrccm.153.2.8564146"},{"key":"BFsrep32544_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1136\/thx.2006.062802","volume":"61","author":"A L\u00f8kke","year":"2006","unstructured":"L\u00f8kke, A., Lange, P., Scharling, H., Fabricius, P. & Vestbo, J. Developing COPD: a 25 year follow up study of the general population. Thorax 61, 935\u2013939 (2006).","journal-title":"Thorax"},{"key":"BFsrep32544_CR18","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","volume":"163","author":"RA Pauwels","year":"2001","unstructured":"Pauwels, R. A. et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 163, 1256\u20131276 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFsrep32544_CR19","doi-asserted-by":"crossref","unstructured":"Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am. Rev. Respir. Dis. 144, 1202\u20131218 (1991).","DOI":"10.1164\/ajrccm\/144.5.1202"},{"key":"BFsrep32544_CR20","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa021322","volume":"350","author":"BR Celli","year":"2004","unstructured":"Celli, B. R. et al. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 1005\u20131012 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep32544_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1134\/S0026893312020082","volume":"46","author":"GF Korytina","year":"2012","unstructured":"Korytina, G. F. et al. [Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease]. Mol. Biol. (Mosk.) 46, 487\u2013499 (2012).","journal-title":"Mol. Biol. (Mosk.)"},{"key":"BFsrep32544_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00005-015-0375-5","volume":"64","author":"Z Navratilova","year":"2016","unstructured":"Navratilova, Z., Kolek, V. & Petrek, M. Matrix Metalloproteinases and Their Inhibitors in Chronic Obstructive Pulmonary Disease. Arch. Immunol. Ther. Exp. (Warsz.) 64, 177\u2013193 (2016).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"BFsrep32544_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1136\/jmg.33.3.233","volume":"33","author":"U Felbor","year":"1996","unstructured":"Felbor, U. et al. A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby\u2019s fundus dystrophy. J. Med. Genet. 33, 233\u2013236 (1996).","journal-title":"J. Med. Genet."},{"key":"BFsrep32544_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/IAE.0b013e318263d3b4","volume":"33","author":"SD Schoenberger","year":"2013","unstructured":"Schoenberger, S. D. & Agarwal, A. A novel mutation at the N-terminal domain of the TIMP3 gene in Sorsby fundus dystrophy. Retina Phila. Pa 33, 429\u2013435 (2013).","journal-title":"Retina Phila. Pa"},{"key":"BFsrep32544_CR25","first-page":"488","volume":"30","author":"A Warwick","year":"2016","unstructured":"Warwick, A., Gibson, J., Sood, R. & Lotery, A. A rare penetrant TIMP3 mutation confers relatively late onset choroidal neovascularisation which can mimic age-related macular degeneration. Eye Lond. Engl. 30, 488\u2013491 (2016).","journal-title":"Eye Lond. Engl."},{"key":"BFsrep32544_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/01902140600817481","volume":"32","author":"J Garc\u00eda-Alvarez","year":"2006","unstructured":"Garc\u00eda-Alvarez, J. et al. Tissue inhibitor of metalloproteinase-3 is up-regulated by transforming growth factor-beta1 in vitro and expressed in fibroblastic foci in vivo in idiopathic pulmonary fibrosis. Exp. Lung Res. 32, 201\u2013214 (2006).","journal-title":"Exp. Lung Res."},{"key":"BFsrep32544_CR27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ydbio.2006.07.004","volume":"298","author":"SE Gill","year":"2006","unstructured":"Gill, S. E., Pape, M. C. & Leco, K. J. Tissue inhibitor of metalloproteinases 3 regulates extracellular matrix\u2013cell signaling during bronchiole branching morphogenesis. Dev. Biol. 298, 540\u2013554 (2006).","journal-title":"Dev. Biol."},{"key":"BFsrep32544_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2353\/ajpath.2010.090158","volume":"176","author":"SE Gill","year":"2010","unstructured":"Gill, S. E. et al. Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury. Am. J. Pathol. 176, 64\u201373 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFsrep32544_CR29","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1093\/emboj\/17.17.5238","volume":"17","author":"C Fernandez-Catalan","year":"1998","unstructured":"Fernandez-Catalan, C. et al. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO J. 17, 5238\u20135248 (1998).","journal-title":"EMBO J."},{"key":"BFsrep32544_CR30","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.jmb.2008.06.088","volume":"381","author":"M Wisniewska","year":"2008","unstructured":"Wisniewska, M. et al. Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex. J. Mol. Biol. 381, 1307\u20131319 (2008).","journal-title":"J. Mol. Biol."},{"key":"BFsrep32544_CR31","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino, R. et al. Interpretative strategies for lung function tests. Eur. Respir. J. 26, 948\u2013968 (2005).","journal-title":"Eur. Respir. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep32544","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T17:21:15Z","timestamp":1672852875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep32544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,10,17]]}},"alternative-id":["BFsrep32544"],"URL":"https:\/\/doi.org\/10.1038\/srep32544","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726717345.793559768","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,7]]},"assertion":[{"value":"9 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32544"}}